Vés al contingut

Phases

  • Phase I
  • Phase II
  • Phase III

TRL 2-3: Basic research and proof of concept


Objectives: 

  • Formulation of the technological concept: Clear definition of the idea and how it can be materialized into a product or technology. 
  • Initial in vitro preclinical studies: Initial tests in laboratories to evaluate the viability and safety of the concept. 
  • Development of the first prototypes: Creation of initial models to test the functionality of the project.
  • Evaluation of technical feasibility: Analysis of feasibility and potential technical challenges. 
  • Scientific documentation: Collection of data and results to structure a solid base for the project.
     

Key Areas: 

  • Regulatory Roadmap: Initial considerations of regulatory requirements. 
  • Market Access: Preliminary market analysis and potential applications. 
  • Intellectual Property: Identification of patentable elements. 
  • Financing: Funding options to continue development. 
  • Business Model & Business Basics: Initial business model sketch. 

TRL 3-4: PoC – Preclinical development


Objectives: 

  • Validation of the experimental proof of concept: Confirmation that the technology works in controlled conditions. 
  • Development of the first prototypes: Improvement of initial prototypes with more solid experimental data. 
  • Validation of the mechanism of action: Detailed study of the product’s functionality and effectiveness. 
  • Preliminary safety evaluation: Initial tests to ensure the technology is safe for further use. 
  • Documentation and scientific reports: Preparation of reports to validate the obtained results.
     

Key Areas:

  • Regulatory Roadmap: Identification of specific regulatory requirements. 
  • Market Access: Study of market viability and identification of potential clients. 
  • Intellectual Property: Legal protection through patents or copyrights. 
  • Financing: Search for new funding sources to advance research. 
  • Business Model: Definition of the business model and commercialization strategy. 

TRL 4-5: Preclinical development


Objectives:

  • Technology validation in the laboratory: Final confirmation of its effectiveness in controlled environments. 
  • Preliminary regulatory interactions: Initial communication with regulatory authorities to ensure compliance. 
  • Determination of regulatory and reimbursement strategy: Definition of how the product will be marketed and how investments will be recovered. 
  • Strategy for scaling the manufacturing process: Planning for large-scale production. 
  • Clinical trial design: Preparation of protocols to start clinical studies in humans.
     

Key Areas: 

  • Regulatory Roadmap: Compliance to move forward to clinical trials. 
  • Market Access: Development of market entry strategies.
  • Intellectual Property: Expansion of intellectual property protection to prevent competition. 
  • Financing: Obtaining funding for the next phases of development. 
  • Business Model: Final definition of the commercial strategy. 

Training program

Regarding the training program, it is divided into 5 main blocks: regulatory, financing, intellectual property, market access and business model.

Additionally, the teams will have access to a pool of hours (25 hours during Phase 1 and 50 hours in Phases 2 and 3) for individual consultations or more personalized training with a pool of mentors. 

Phase I | Basic research and proof of concept

Business Basics

  • Analysis of scientific versus business competencies
  • Creative process with a focus on the market
  • Process of identifying technology valuation:
    • Licensing
    • Company creation
  • Practical case examples in the field of advanced therapies 

3 hours

Regulatory Affairs

  • Introduction to Advanced Therapy Medicinal Products (ATMPs)
  • Lifecycle of an ATMP: From Concept to Commercialization
  • Global Regulatory Requirements for ATMPs
  • Common Regulatory Challenges and Solution Strategies 

4 hours

Market Access

  • Introduction to Market Access
  • Early Market Access 

2.5 hours

Intellectual Property

  • Tools for protecting industrial and intellectual property for advanced therapy projects.
  • Patents in the field of advanced therapies: When to apply for a patent and what technical information is needed based on the case.
    • Case Study 1: Protection in the field of cell therapy and tissue regeneration.
    • Case Study 2: Protection in the field of antibodies and derivatives. 

4 hours

Financing

  • Public Funding Opportunities for Biotech Projects
  • Overview of financing strategies in life sciences
  • Non-dilutive funding sources
  • Private funding mechanisms
  • In-depth analysis of venture capital (VC)
  • Practical case study: Real-life example of company creation in ATMPs

5 hours

Business Cases

Practical case study of a fictional company analyzed from different perspectives (financing strategy, IP, regulation, etc.) 

3 hours

Phase II - PoC – Preclinical development

  • Identification of specific regulatory requirements.
  • Market feasibility study and identification of potential clients.
  • Legal protection through patents or copyrights.
  • Seeking new funding sources to advance the research.

Phase III – Preclinical Development

  • Regulatory compliance to advance toward clinical trials.
  • Establishment of market entry strategies.
  • Expansion of intellectual property protection.
  • Securing funding for next development phases.
Subscriu-te a les nostres newsletters

Totes les novetats de Biocat i del sector de les ciències de la vida i la salut a la teva safata d'entrada.